Kos and SkyePharma Sign Exclusive License Agreement for the Marketing (Skye Sweetnam)

Kos and SkyePharma Sign Exclusive License Agreement for the Marketing
Money Plans - Kos Life Sciences, Inc., a subsidiary of Kos Pharmaceuticals, Inc. (Nasdaq: KOSP) and Jagotec AG, a subsidiary of SkyePharma PLC (Nasdaq:SKYE; LSE: SKP), announced today the signing of an exclusive agreement for the marketing and distribution in the
Source: www.moneyplans.net